Transcripts Replimune Group, Inc.

Actions

REPL

US76029N1063

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 18/06/2026			Varia. 5j.	Varia. 1 janv.
10,19 ^USD	+1,90 %		+14,75 %	+4,84 %

01/06	Replimune évalue le RP2 contre le mélanome uvéal métastatique en phase 2/3 ; le titre grimpe en pré-séance	MT
31/05	Replimune Group présente les données finales de la première étude chez l'homme pour RP2 dans les tumeurs solides avancées	CI

Transcripts

15/01	Transcript : Replimune Group, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 01:30 PM
24/06/25	Transcript : Replimune Group, Inc. - Analyst/Investor Day
22/05/25	Transcript : Replimune Group, Inc., Q4 2025 Earnings Call, May 22, 2025
13/01/25	Transcript : Replimune Group, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 02:15 PM
11/06/24	Transcript : Replimune Group, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 02:00 PM
06/06/24	Transcript : Replimune Group, Inc. - Special Call
14/03/24	Transcript : Replimune Group, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 10:45 AM
08/01/24	Transcript : Replimune Group, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 11:15 AM
05/12/23	Transcript : Replimune Group, Inc. - Special Call
09/01/23	Transcript : Replimune Group, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:45 AM
07/12/22	Transcript : Replimune Group, Inc. - Special Call
07/09/22	Transcript : Replimune Group, Inc. - Shareholder/Analyst Call
30/03/22	Transcript : Replimune Group, Inc. - Analyst/Investor Day
10/01/22	Transcript : Replimune Group, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 07:30 AM
08/09/21	Transcript : Replimune Group, Inc. - Shareholder/Analyst Call
03/06/21	Transcript : Replimune Group, Inc. - Special Call
11/03/21	Transcript : Replimune Group, Inc. Presents at Barclays Global Healthcare Conference 2021, Mar-11-2021 09:10 AM
12/01/21	Transcript : Replimune Group, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 02:20 PM
03/06/20	Transcript : Replimune Group, Inc. - Special Call
15/01/20	Transcript : Replimune Group, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-14-2020 05:00 PM
09/11/19	Transcript : Replimune Group, Inc. - Special Call
09/01/19	Transcript : Replimune Group, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 08:00 AM
14/11/18	Replimune Group, Inc. annonce des résultats consolidés non audités pour le deuxième trimestre et le semestre clos le 30 septembre 2018 ; fournit des prévisions de résultats pour le deuxième semestre 2021.	CI